Business Context and Reporting Period
This Form 8-K Current Report was filed by Inpixon (trading symbol: INPX) on December 19, 2019. The report details a material definitive agreement entered into on the same date between the Company and Chicago Venture Partners, L.P. ("CVP"). Note: The request metadata references "XTI Aerospace, Inc.", but the filing text explicitly identifies the registrant as "Inpixon".
Key Financial Metrics and Transaction Details
- Debt Reduction: The Company reduced its outstanding debt balance by $645,000 through an exchange agreement.
- Original Note Balance: As of December 19, 2019, the total outstanding balance on the specific note held by CVP was $3,658,419.34.
- Equity Issuance: The Company issued 10,750,000 shares of Common Stock to CVP.
- Effective Price: The exchange was executed at an effective price of $0.06 per share.
- Total Outstanding Debt (Affiliates): As of December 11, 2019, CVP and its affiliates held promissory notes with an aggregate outstanding balance of approximately $6.24 million ($4.14 million held by CVP, $1.19 million by Iliad Research and Trading, L.P., and $957,500 by St. George Investments LLC).
- Cash Flow: The filing text does not provide specific cash flow figures for the period; the transaction was a non-cash exchange of debt for equity.
Material Changes Versus Prior Period
The primary material change is the conversion of a portion of the Company's debt obligations into equity. Specifically, a partitioned note of $645,000 was extinguished in exchange for 10,750,000 shares of Common Stock. This transaction increased the total issued and outstanding Common Stock to 127,689,581 shares as of December 19, 2019.
Guidance, Outlook, and Risks
- Regulatory Exemption: The issuance of shares was unregistered, relying on an exemption under Section 3(a)(9) of the Securities Act of 1933, as no additional consideration was paid and no commissions were involved.
- Settlement Terms: Shares were scheduled for delivery on or before December 23, 2019, contingent upon CVP surrendering the partitioned note upon approval by their brokerage firm for public resale.
- Capital Structure: In addition to Common Stock, the Company has outstanding Series 4 and Series 5 Convertible Preferred Stock and warrants exercisable at $3.33 and $0.2775 per share, respectively.
- Outlook: The filing does not contain forward-looking guidance or management commentary regarding future financial performance.
Investor Verification Checklist
- Verify the current trading status and volume of INPX on the Nasdaq Capital Market following the issuance of 10.75 million new shares.
- Confirm the total remaining debt balance owed to CVP and its affiliates after the $645,000 reduction.
- Review the full text of the Exchange Agreement (Exhibit 10.1) for any covenants or restrictions not summarized in the 8-K.
- Assess the dilution impact of the 10,750,000 new shares on existing shareholders.
- Check for any subsequent filings regarding the settlement of the remaining debt held by CVP affiliates.